Chris Olave Clears the Blood-Clot Hurdle: Off Blood Thinners and on Track for Saints Camp

Chris Olave is on the cusp of clearing the most important hurdle of his offseason. The Saints receiver, who missed the final week of last season after being diagnosed with a blood clot in his lung, is reported to come off blood thinners on or around June 29, according to a report from ProFootballTalk. That milestone sets up a path to full clearance in time for the start of New Orleans training camp, and it changes the fantasy calculus on a talented wideout whose stock had been frozen by uncertainty.

The framing from those close to the situation has been consistent: everything to this point has gone exactly as planned. That is the language fantasy managers want to hear about a player who, when healthy, is one of the more polished route runners in the league.

What is confirmed and what is not

Olave did individual-only work throughout the offseason program and was held out of team activities at OTAs and minicamp, which is standard caution for an athlete on blood thinners, since contact carries bleeding risk. As of mid-June, NFL.com reported he was still not fully cleared for all football activities. The June 29 date to come off the medication is the key step that unlocks the rest.

The realistic timeline has him ramping back up with training camp roughly a month out, which gives him a runway to be a full participant when camp opens. None of this is a guarantee until he is on the practice field in pads, but the trend line is positive and the messaging has been encouraging rather than hedged.

The medical context matters

A pulmonary blood clot is a serious diagnosis, and it is fair to flag the history as a real risk rather than wave it away. The reassuring part is that this type of clot is typically treated and resolved over a defined course of blood thinners, and coming off the medication on schedule is the signal that the treatment worked as intended. The cautionary part is that any clot history is something a player and team monitor going forward.

For fantasy purposes, that means Olave carries a slightly elevated risk tag relative to a receiver with a clean recent medical sheet, even if he is cleared to play. Draft him accordingly: as a buy-low with real upside, not as a player you pay a premium for.

Fantasy fallout

Olave is a recovery riser. When he is right, he is a high-volume target earner who can function as a WR2 in fantasy lineups, and the price has been suppressed all offseason precisely because managers could not be sure he would be on the field. If the June 29 milestone passes cleanly and he practices in camp, expect his average draft position to climb as the market gains confidence.

The variable that caps his ceiling is the New Orleans quarterback situation, which remains unsettled. Olave's target volume is not really in question if he is healthy, but his efficiency and big-play output depend on who is throwing him the ball. Bake that into your valuation: the floor is the target share, the ceiling depends on the passer.

The Verdexed model take

Verdexed's model has carried Olave at a discount all spring, applying an availability penalty while he was unable to practice. The June 29 report is the kind of input that shrinks that penalty. Once he logs a full camp practice, the model is positioned to move him back toward his pre-injury range as a WR2 with WR1 upside in the right matchup.

The confirming trigger is simple and concrete: the first camp practice report that has Olave working full-go with the team. That single data point will do more for his projection than any amount of offseason optimism. Until then, he is a smart target for managers comfortable buying a recovering asset at a discount.

The wider Saints passing-game picture

Olave's outlook does not exist in a vacuum, and the rest of the New Orleans pass-catching group shapes how much his target share is worth. When healthy, Olave has been the clear focal point of the Saints' aerial attack, the kind of separator who earns a heavy share regardless of who else is on the field. That target concentration is exactly what makes him fantasy-relevant even in an offense whose ceiling is capped by quarterback uncertainty.

The flip side is that a target-funnel role is most valuable when the quarterback can actually deliver the ball with accuracy and on time. If New Orleans gets stable, competent quarterback play, Olave's volume converts into WR2 production. If the passing game sputters, he becomes a high-target, low-efficiency player whose box scores frustrate managers despite the workload. That is the central tension in his valuation, and it is why the quarterback battle is worth tracking right up to your draft.

For now, the health milestone is the news, and it is a clear positive. A target-earning number one receiver coming off the medical list at a discount is the kind of asset that wins drafts when the recovery holds. Just pair the optimism about his role with clear eyes about the offense around him, and price him as the high-upside, moderate-risk play he is rather than as a locked-in weekly starter.

What to do in your league

Treat Olave as a value with a clear catalyst. If your draft is before camp opens, you may get him a tier cheaper than his talent warrants because nervous managers are still pricing in the injury. If your draft is after the first padded practices and he looks like himself, the discount will likely be gone. Either way, keep his quarterback situation on your radar, and do not be the manager who forgets to check the camp report on the morning of your draft.